Stay updated with breaking news from Gamida Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AlloVir Appoints Shawn Tomasello to Its Board of Directors Waltham, Mass., March 31, 2022 - AlloVir , a late-clinical stage allogeneic T-cell immunotherapy... | March 31, 2022
The biotechnology sector received ample cash flow injections during 2020, when COVID-19 testing, research, and vaccine development was at its peak.
Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) – Equities researchers at Oppenheimer lowered their Q1 2022 EPS estimates for Gamida Cell in a report issued on Tuesday, March 15th. Oppenheimer analyst M. Breidenbach now expects that the company will post earnings of ($0.38) per share for the quarter, down from their prior estimate of ($0.32). […]
Gamida Cell (NASDAQ:GMDA – Get Rating) posted its quarterly earnings results on Tuesday. The company reported ($0.52) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.44) by ($0.08), Fidelity Earnings reports. During the same quarter in the prior year, the company posted ($0.68) EPS. Shares of GMDA stock traded up […]
Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) was the recipient of a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 2,280,000 shares, a drop of 15.9% from the February 13th total of 2,710,000 shares. Approximately 5.6% of the shares of the company are short […]